Yangjisa Co., Ltd. (KOSDAQ:030960)
5,960.00
-290.00 (-4.64%)
At close: May 20, 2026
Yangjisa Revenue
Yangjisa had revenue of 6.65B KRW in the quarter ending March 31, 2022, a decrease of -68.76%. This brings the company's revenue in the last twelve months to 45.16B, down -7.33% year-over-year. In the fiscal year ending June 30, 2012, Yangjisa had annual revenue of 51.69B with 10.55% growth.
Revenue (ttm)
45.16B
Revenue Growth
-7.33%
P/S Ratio
1.81
Revenue / Employee
125.79M
Employees
359
Market Cap
81.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2012 | 51.69B | 4.93B | 10.55% |
| Jun 30, 2011 | 46.75B | 433.81M | 0.94% |
| Jun 30, 2010 | 46.32B | 271.88M | 0.59% |
| Jun 30, 2009 | 46.05B | 5.05B | 12.32% |
| Jun 30, 2008 | 41.00B | 459.95M | 1.13% |
| Jun 30, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NVH Korea | 1.62T |
| The LEADCORP | 387.71B |
| Insung Information | 342.74B |
| Keum Kang Steel | 177.22B |
| Jeil M&S | 151.27B |
| Nice D&B | 91.36B |
| APS Inc. | 84.87B |
| Icure Pharmaceutical Incorporation | 83.38B |